These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2999530)

  • 1. Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses.
    Fuxe K; Agnati LF
    Med Res Rev; 1985; 5(4):441-82. PubMed ID: 2999530
    [No Abstract]   [Full Text] [Related]  

  • 2. A glutamate mechanism in the intermediolateral nucleus mediates sympathoexcitatory responses to stimulation of the rostral ventrolateral medulla.
    Morrison SF; Ernsberger P; Milner TA; Callaway J; Gong A; Reis DJ
    Prog Brain Res; 1989; 81():159-69. PubMed ID: 2575775
    [No Abstract]   [Full Text] [Related]  

  • 3. S-Glutamate: its interactions with spinal neurons.
    Puil E
    Brain Res; 1981 Dec; 228(3):229-322. PubMed ID: 6118198
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonopioid neuropeptides in mammalian CNS.
    Iversen LL
    Annu Rev Pharmacol Toxicol; 1983; 23():1-27. PubMed ID: 6191652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neurotensin/dopamine interactions].
    Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
    Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
    [No Abstract]   [Full Text] [Related]  

  • 6. Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil.
    Urban MO; Jiang MC; Gebhart GF
    Brain Res; 1996 Oct; 737(1-2):83-91. PubMed ID: 8930354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central neurotensin inhibits gastric acid secretion: an adrenergic mechanism in rats.
    Zhang L; Xing LP; Demers L; Washington J; Kauffman GL
    Gastroenterology; 1989 Nov; 97(5):1130-4. PubMed ID: 2551763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
    Lambert PD; Gross R; Nemeroff CB; Kilts CD
    Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
    [No Abstract]   [Full Text] [Related]  

  • 9. In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms.
    Abrams WB
    Hypertension; 1984; 6(5 Pt 2):II87-93. PubMed ID: 6150004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin and dopamine interactions.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Pharmacol Rev; 2001 Dec; 53(4):453-86. PubMed ID: 11734615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides and their receptors: a psychosomatic network.
    Pert CB; Ruff MR; Weber RJ; Herkenham M
    J Immunol; 1985 Aug; 135(2 Suppl):820s-826s. PubMed ID: 2989371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate synapses and receptors on insect muscle.
    Usherwood PN
    Adv Biochem Psychopharmacol; 1981; 27():183-93. PubMed ID: 6108693
    [No Abstract]   [Full Text] [Related]  

  • 13. Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat.
    Agnati LF; Fuxe K; Battistini N; Giardino L; Benfenati F; Martire M; Ruggeri M
    Acta Physiol Scand; 1985 May; 124(1):125-8. PubMed ID: 2990164
    [No Abstract]   [Full Text] [Related]  

  • 14. Colocalization of receptors for vasoactive peptides on astrocytes of cultured rat spinal cord and brain stem: electrophysiological effects of atrial and brain natriuretic peptide, neuropeptide Y and bradykinin.
    Hösli L; Hösli E; Kaeser H; Lefkovits M
    Neurosci Lett; 1992 Dec; 148(1-2):114-6. PubMed ID: 1338645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers.
    Fuxe K; Härfstrand A; Agnati LF; Kalia M; Fredholm B; Svensson T; Gustafsson JA; Lang R; Ganten D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S1-13. PubMed ID: 2455156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulating chemical transmitter systems in the brain].
    Herrling PL
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):41-57. PubMed ID: 2431472
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
    Bleakman D; Rusin KI; Chard PS; Glaum SR; Miller RJ
    Mol Pharmacol; 1992 Aug; 42(2):192-6. PubMed ID: 1381041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-receptor interactions and their relevance for receptor diversity. Focus on neuropeptide/dopamine interactions.
    Fuxe K; Li XM; Tanganelli S; Hedlund P; O'Connor WT; Ferraro L; Ungerstedt U; Agnati LF
    Ann N Y Acad Sci; 1995 May; 757():365-76. PubMed ID: 7611694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of neurotransmitter chemistry of central nervous system neurons in primary tissue culture.
    Thomas WE
    Life Sci; 1986 Jan; 38(4):297-308. PubMed ID: 2418325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity.
    Manev H; Costa E; Wroblewski JT; Guidotti A
    FASEB J; 1990 Jul; 4(10):2789-97. PubMed ID: 2165013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.